Bogotá_Business_Center (1).jpg

We help bio/pharma & medical device companies obtain cost-effective clinical data by operationalizing their clinical trials in Colombia for Fast FDA/CE Mark approval

We also help them find a distributor and register their products for sales in Colombia

Imagine if you could shorten your trial start-up time, save about 50% on your trial costs, and access a market with a 50-million population with universal health coverage

You don't have to imagine it. In fact, we have created a way to easily bring Colombia's excellent clinical research capacity to you so that you run your clinical trial and register your product for sales TODAY. Colombia has the fastest regulatory approval time in Latin America!

Trusted by

I can only say good things about our experience in Colombia.
— John B. Simpson, MD. CEO, Avinger, Inc.
I can’t express how thankful we were for your assistance. Colombia was an incredible experience and I will for sure be back to visit.
— Victor Chong, Chief Operating Officer at Above and Beyond NB, LLC

Shorten trial start-up. Lower your costs. Recruit more patients, faster. Sell your product. All in Colombia!

  1. Fast approval at the MoH (after IRB approval): 30 days for medical devices and 60 days for pharma and biotech. 
  2. Savings: Save about 50% on your clinical trial costs.
  3. Easier patient recruitment: Population of 50 million with universal healthcare coverage and unparalleled patient pool.

CenterWatch is talking about Colombia

The combination of good healthcare (95% of Colombian citizens have health insurance), an already strong clinical trial industry, stringent regulations issued in 2008 that requires sites to be certified by INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) and a relatively quick and predictable approval process for launching a trial has made it a desirable clinical trial destination.
— Ronald Rosenberg, CenterWatch Weekly, April 6, 2015

The government of Colombia, in collaboration with the clinical development firm Interventional Concepts, is actively seeking to promote Colombia as a destination for early-stage clinical trials. Between 1995 and 2013, 738 clinical trials were conducted in the country. Although approximately 90 percent of those studies were in the pharmaceutical space, a growing number are being performed in the medical technology field for companies such as Avinger, Kona Medical, and InterValve.
— Stanford University, Biodesign

When it comes to launching early clinical trials for medical devices, the three leading Latin American countries are Colombia, Paraguay and Chile...Colombia also is relatively close to the East Coast with short flights, has a stable government and is the only country trying to attract startups and small companies for phase I. It is harder and more costly to do early stage trials in the U.S., and Colombia hospitals and some doctors have close relationships with the University of Miami Medical School, a teaching hospital.
— Jonathan Rourke, CEO & co-founder, Mitraspan, Inc., CenterWatch Weekly, April 6, 2015

Who we are

Interventional Concepts is a Miami, FL-based contract research organization (CRO), and a market access and regulatory consulting company for medical device, biotechnology, and pharmaceutical companies looking to conduct their clinical trials, or looking to sale their products in Colombia. We help life science companies with study design, site selection, trial set-up, project management, regulatory submission, product importation and logistics, data management, statistical analysis, study monitoring, medical writing, product registration for sales, distributor search and selection, and with consulting services related to commercialization and and regulatory matters. Learn more.



How we help

Our medical device, biotechnology, and pharmaceutical clients trust us to search, evaluate and select the best site in Colombia where they can conduct their clinical trials. We help with medical device development, study design, site selection, trial set-up, regulatory submission, logistics (import, distribution, disposal, export), project management, study monitoring, statistical analysis, data management, medical writing, product registration for sales, distributor search and selection, and other clinical, commercialization and regulatory consulting services. Read more


Get a FREE Colombia Clinical Trial Guide

Learn the regulatory pathway to approve your clinical trial faster, save money and recruit patients easier. 

We help you register your product for sales in Colombia, and to search and select a distributor

Leadership Team

We have a true passion for medical innovation

We believe that Colombia represents an untapped opportunity for life science startup companies to conduct cost-effective, quality and ethical clinical trials —with the same quality standards that they would find in the U.S. or Europe. We also believe Colombia is an untapped market for life science innovators to sell their products. 

Pedro Martinez-Clark, M.D.

Founder & Chief Medical Officer

Pedro is an interventional cardiologist trained at Harvard University's Beth Israel Deaconess Medical Center. He later became assistant professor at the Miller School of Medicine at the University of Miami where he worked side-by-side with the internationally renowned William O'Neill, M.D. Dr. Martinez-Clark has extensive experience in clinical research and program development. With board certifications in internal medicine, cardiovascular medicine and interventional cardiology. Dr. Martinez-Clark has developed an international cardiovascular practice in Miami, FL.  Read more

Julio G. Martinez-Clark, M.B.A.

President & CEO

Julio is a Colombian-born savvy leader with an indelible reputation for delivering inventive and growth-focused business strategies. Recognized for his entrepreneurial spirit, grit and vision that build the foundation for successful startup ventures. Julio is the founder of the Founder and leader of two LinkedIn groups: Foreign Clinical Trials Forum | The Group for Life Science Executives Looking to Run Foreign Trials, and the Foro de Investigación Clínica: el grupo para el avance de la investigación clínica en Colombia. Read more

Michael A. Alvarez

Chief Business Officer

Michael has over 25 years of senior leadership and management experience in business development, sales and marketing, communications, and strategic partnering within health care and biomedical industry settings. He was founding director for centers for professional development and entrepreneurship at three globally renowned institutions (Stanford, UCSF, and MD Anderson Cancer Center).